Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

ME

23andMe (ME)

23andMe Holding Company
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ME
DateTimeSourceHeadlineSymbolCompany
06/10/20243:17PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ME23andMe Holding Company
06/05/20246:00AMGlobeNewswire Inc.23andMe Launches New Genetic Report on Bipolar DisorderNASDAQ:ME23andMe Holding Company
06/04/20246:00AMGlobeNewswire Inc.23andMe and the Colorectal Cancer Alliance Collaborate to Help Advance Colorectal Cancer Research in the Black CommunityNASDAQ:ME23andMe Holding Company
06/03/20247:06AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ME23andMe Holding Company
06/03/20247:00AMGlobeNewswire Inc.23andMe Therapeutics Announces Positive Preliminary Phase 2 Safety and Efficacy Results for 23ME-00610, targeting CD200R1, at the 2024 ASCO Annual MeetingNASDAQ:ME23andMe Holding Company
05/29/20247:00AMGlobeNewswire Inc.Largest study on the LRRK2 variant leads to discoveries about health, ancestry, and historyNASDAQ:ME23andMe Holding Company
05/24/20243:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ME23andMe Holding Company
05/23/20244:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ME23andMe Holding Company
05/23/20243:07PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ME23andMe Holding Company
05/23/20243:05PMGlobeNewswire Inc.23andMe Reports Fourth Quarter and Full Year Fiscal 2024 Financial ResultsNASDAQ:ME23andMe Holding Company
05/21/20243:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ME23andMe Holding Company
05/21/20243:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ME23andMe Holding Company
05/14/20246:00AMGlobeNewswire Inc.Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros PharmaceuticalsNASDAQ:ME23andMe Holding Company
05/10/20243:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ME23andMe Holding Company
05/09/20243:50PMGlobeNewswire Inc.23andMe to Report Q4 and Full Year FY2024 Financial ResultsNASDAQ:ME23andMe Holding Company
04/30/202410:00AMBusiness WirePotter Handy Law Firm Represents Nearly 5,000 Clients in 23andMe Data Breach CaseNASDAQ:ME23andMe Holding Company
04/24/20243:05PMGlobeNewswire Inc.23andMe to Present Preliminary Efficacy and Biomarker Data for 23ME-00610 at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:ME23andMe Holding Company
04/18/20247:00AMGlobeNewswire Inc.23andMe announces CEO’s intention to pursue a potential take-privateNASDAQ:ME23andMe Holding Company
04/05/20243:05PMGlobeNewswire Inc.23andMe to Present Data on Two Clinical Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024NASDAQ:ME23andMe Holding Company
03/20/20246:30AMGlobeNewswire Inc.23andMe Initiates Phase 1 Clinical Trial for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6NASDAQ:ME23andMe Holding Company
03/19/20247:00AMGlobeNewswire Inc.23andMe Launches New Feature Connecting Customers to Historical Individuals from Hundreds and Even Thousands of Years AgoNASDAQ:ME23andMe Holding Company
03/06/20246:30AMGlobeNewswire Inc.23andMe Launches New Genetic Reports on Common Forms of CancerNASDAQ:ME23andMe Holding Company
03/05/20243:30PMGlobeNewswire Inc.23andMe Announces Three Presentations from Clinical-Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024NASDAQ:ME23andMe Holding Company
02/21/20243:36PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ME23andMe Holding Company
02/07/20243:07PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ME23andMe Holding Company
02/07/20243:03PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ME23andMe Holding Company
02/07/20243:01PMGlobeNewswire Inc.23andMe Reports Third Quarter Fiscal 2024 Financial ResultsNASDAQ:ME23andMe Holding Company
02/06/20246:00AMBusiness WireMoneta Gold and Nighthawk Gold Complete At-Market Merger to form STLLR Gold Inc.NASDAQ:ME23andMe Holding Company
01/31/20246:50AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ME23andMe Holding Company
01/30/20249:12PMGlobeNewswire Inc.23andMe Launches Month-Long Initiative to Amplify ARRAY’s “Seat16” Program for Acclaimed Film ORIGIN by Ava DuVernayNASDAQ:ME23andMe Holding Company
 Showing the most relevant articles for your search:NASDAQ:ME